LIFE SCIENCES Archives

Traditional Chinese Medicine: Ready for the Global Stage?

07/09/2016by EOS Intelligence

In late 2015, Chinese researcher Tu Youyou was awarded the Nobel Prize for creating anti-malaria drug, using Traditional Chinese Medicine (TCM). Artemisinin, an active compound extracted from an aromatic herb...

FDI Regulations in Indian Pharmaceutical Sector: A Game-changer?

20/07/2016by EOS Intelligence

In June 2016, the Indian government liberalized its FDI policy in the pharmaceuticals sector by allowing 74% FDI under automatic route in brownfield pharmaceutical investments (investment in an existing plant)....

Government Trumps Pfizer Deal

07/04/2016by EOS Intelligence

Since its announcement last year, a US$160 billion Pfizer-Allergan merger has been under an ongoing discussion, with great synergies and tax savings expected if the deal was to be finalized,...

Pfizer-Allergan Deal – What’s in Store for Allergan

03/02/2016by EOS Intelligence

In November 2015, Pfizer and Allergan announced a US$160 billion merger deal. Once finalized, the Pfizer-Allergan deal would follow three large mergers/acquisitions concluded by Pfizer in the last 15 years....

Global Pharmaceutical Market Scenario – Challenges, Action Plan and Potential Outcome

07/11/2013by EOS Intelligence

Global pharmaceutical companies have suffered considerably on the face of patent expiry and lack of robust product pipeline in the last four-odd years. It is estimated that drug companies have...

The ASEAN Pharmaceutical Market – Measure of Attractiveness

16/07/2013by EOS Intelligence

The ASEAN region, home to more than 600 million people, has historically been an attractive market for international pharmaceutical companies. With the exception of Indonesia, all other countries in the...

Will Pharma Tweet Louder? 6 Rules of Doing it Right on Social Media

23/05/2013by EOS Intelligence

Initially considered to be exclusively a tool for common people to connect with friends and share their private pictures, social media platforms have now gained the status of a potent...

Essential Drugs in India – Is It All About Affordability?

13/12/2012by EOS Intelligence

For a pharmaceutical company, establishing a balance between production cost, profitability and affordability of the drug for consumers is a delicate matter, with natural temptation to push the aspect of...

Who We Are

Connect With Us

Work With EOS